Brooke Heiple
Acute Care · Johnstown, PANPI 1467014050
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 19 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 18.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $186 and has fallen 80.4% since, to $37 in 2025.
Across 19 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$73
- Averitas Pharma Inc.$47
- Amylyx Pharmaceuticals, Inc.$38
- Alkermes, Inc.$37
- Merz Pharmaceuticals, LLC$35
- Ipsen Biopharmaceuticals, Inc$33
- plus $125 from 5 others
What the payments were for
- Food & beverage$389100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $73 |
| Averitas Pharma Inc. | 2 | $47 |
| Amylyx Pharmaceuticals, Inc. | 2 | $38 |
| Alkermes, Inc. | 2 | $37 |
| Merz Pharmaceuticals, LLC | 1 | $35 |
| Ipsen Biopharmaceuticals, Inc | 2 | $33 |
| Pfizer | 2 | $32 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Organon | 1 | $24 |
| Tactile Systems Technology Inc | 1 | $24 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
How this compares
$389 in reported general payments places this provider in the 60th percentile of 872 acute care providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 133 | $2,676 |
| Baclofen | 66 | $1,679 |
| Tizanidine Hcl | 90 | $1,230 |
| Duloxetine Hcl | 49 | $879 |
| Amitriptyline Hcl | 46 | $784 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 17 | $670 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 23 | $662 |
| Methocarbamol | 21 | $485 |
| Pregabalin | 23 | $443 |
| Propranolol Hcl | 12 | $142 |
| Ibuprofen | 11 | $131 |
| Cyclobenzaprine Hcl | 14 | $119 |
| Tramadol Hcl | 15 | $45 |
Paid to pharmacies, not to this prescriber.
Other acute care in Johnstown
- Nadine ZatsickJohnstown$4K
- Kristi MontrellaAltoona$111K
- Kathryn GreenPhiladelphia$92K
- Caroline PratzPhiladelphia$77K
- Donna KinzlerPittsburgh$25K
- Lisa JohnsonPottstown$25K
- Kathryn McParlaneMoon Township$21K
- Rebecca MarcantuonoPhiladelphia$17K
- Stephanie TothPhiladelphia$17K
- Kevin HaganAbington$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.